Trademarkia Logo

Australia

AU$
THALIDOMIDE CELGENE
Protected: Registered/protected

Last updated on 7 Sept 2023

Owner Info

Celgene Corporation

86 Morris Avenue

Summit, NJ 07901, UNITED STATES OF AMERICA

Serial Number

1275520 filed on 23 Oct 2008

Correspondent

KIRKPATRICK, SA/NV

Avenue Wolfers 32,

B-1310 La Hulpe,

BELGIUM

THALIDOMIDE CELGENE

Classification Information


Class [005]
Pharmaceutical preparations that contain thalidomide used to treat cancers and immune related diseases

Mark Details


Serial Number

1275520

Registered On

23 Oct 2008

Renewal On

23 Oct 2028

Mark Type

WORD

Legal History


Show more

Status DateAction Taken
7th Sept 2023Amendment to International Registration Contact Requested
6th May 2021Amendment to International Registration Contact Requested
13th Nov 2018Renewal Requested
6th Nov 2018Registration Status Change
23rd Apr 2018Registration Status Change
10th Sept 2015Amendment to Application/Registration
24th Feb 2012Goods and Services Classes
24th Feb 2012Goods and Services description amendment
23rd Feb 2012Amend Trade Mark Registration Particulars
24th Jul 2009Amend Trade Mark Registration Particulars